These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27258228)

  • 1. Outcomes of Various Treatment Strategies for Patients with Continuous-Flow Ventricular Assist Device Thrombosis: A Retrospective Analysis.
    Ertugay S; Engin C; Daylan A; Pektok E; Ozturk P; Nalbantgil S; Zoghi M; Yagdi T; Ozbaran M
    ASAIO J; 2016; 62(5):533-8. PubMed ID: 27258228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management.
    Jennings DL; Weeks PA
    Pharmacotherapy; 2015 Jan; 35(1):79-98. PubMed ID: 25329333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited Efficacy of Thrombolytics for Pump Thrombosis in Durable Left Ventricular Assist Devices.
    Seese L; Hickey G; Keebler M; Thoma F; Kilic A
    Ann Thorac Surg; 2020 Dec; 110(6):2047-2054. PubMed ID: 32348739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative approaches for HeartWare ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches.
    Saeed D; Maxhera B; Albert A; Westenfeld R; Hoffmann T; Lichtenberg A
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):90-5. PubMed ID: 26993475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication management for left ventricular assist device thrombosis.
    Hohner E; Crow J; Moranville MP
    Am J Health Syst Pharm; 2015 Jul; 72(13):1104-13. PubMed ID: 26092961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment with a new protocol using tissue-type plasminogen activator thrombolysis for pump thrombosis with the HVAD device.
    Schrage B; Grahn H; Wagner FM; Bernhardt A; Rybczynski M; Blankenberg S; Reichenspurner H; Barten MJ
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):766-770. PubMed ID: 28058856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System: A Novel Approach Using Log File Analysis.
    Jorde UP; Aaronson KD; Najjar SS; Pagani FD; Hayward C; Zimpfer D; Schlöglhofer T; Pham DT; Goldstein DJ; Leadley K; Chow MJ; Brown MC; Uriel N
    JACC Heart Fail; 2015 Nov; 3(11):849-56. PubMed ID: 26454842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.
    Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward CS
    Artif Organs; 2013 Mar; 37(3):313-8. PubMed ID: 23373528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange.
    Urban M; Um J; Moulton M; Stoller D; Zolty R; Lowes B; Macdonald C; McCain N; Siddique A
    Int J Artif Organs; 2020 Feb; 43(2):109-118. PubMed ID: 31530254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist device pump thrombosis: is there a role for glycoprotein IIb/IIIa inhibitors?
    Bellumkonda L; Subrahmanyan L; Jacoby D; Bonde P
    ASAIO J; 2014; 60(1):134-6. PubMed ID: 24335386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.
    Bitar A; Vijayakrishnan R; Lenneman A; Birks E; Massey T; Slaughter M; Abramov D
    Artif Organs; 2017 Dec; 41(12):1092-1098. PubMed ID: 28621461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis in left ventricular assistance device with centrifugal technology: is early thrombolysis a better solution?
    Centofanti P; Baronetto A; Attisani M; Ricci D; Simonato E; La Torre MW; Boffini M; Rinaldi M
    Int J Artif Organs; 2017 Oct; 40(11):629-635. PubMed ID: 28777390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Treatment Algorithm for Blood Flow Obstructions in Patients With Left Ventricular Assist Device.
    Scandroglio AM; Kaufmann F; Pieri M; Kretzschmar A; Müller M; Pergantis P; Dreysse S; Falk V; Krabatsch T; Potapov EV
    J Am Coll Cardiol; 2016 Jun; 67(23):2758-2768. PubMed ID: 27282897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis in Continuous Flow Left Ventricular Assist Devices: Our Clinical Experience With Medical and Surgical Management.
    Köksel U; Erbasan O; Bayezid Ö; Kemaloğlu C; Özçobanoğlu S; Gölbaşı I; Türkay C
    Transplant Proc; 2016; 48(6):2162-7. PubMed ID: 27569964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial conservative management strategy of HeartWare left ventricular assist device thrombosis with intravenous heparin or bivalirudin.
    Bouzas-Cruz N; Gonzalez-Fernandez O; Ferrera-Durán C; Woods A; Robinson-Smith N; Tovey S; Jungschleger J; Booth K; Shah A; Parry G; MacGowan GA; Schueler S
    Int J Artif Organs; 2020 Jul; 43(7):444-451. PubMed ID: 31885316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tirofiban in Suspected Left Ventricular Assist Device Pump Thrombosis.
    Nei SD; Wieruszewski PM; Orzel LA; Ritchie BM; Stulak JM
    ASAIO J; 2020 Aug; 66(8):886-889. PubMed ID: 32740348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
    Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.